Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Propylene Glycol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 5/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propylene Glycol SCHEMBL27888673 | 0.97 | TDP1 (0.53) | TDP1TSHRMAPK1HSD17B10LMNA | |
| Glycerin SCHEMBL3433694 | 0.86 | LMNA (0.47) | TDP1TSHRMAPK1LMNAALDH1A1 | |
| SCHEMBL224938 | 0.86 | — | — | |
| SCHEMBL13254103 | 0.86 | — | — | |
| Alcohol SCHEMBL10454582 | 0.85 | TSHR (0.40) | TDP1TSHRMAPK1ALDH1A1 | |
| Ethylene Glycol SCHEMBL4899588 | 0.82 | TSHR (0.38) | TDP1TSHRMAPK1ALDH1A1 | |
| SCHEMBL14000783 | 0.82 | — | — | |
| SCHEMBL147241 | 0.82 | — | — | |
| SCHEMBL5791362 | 0.82 | — | — | |
| SCHEMBL17662747 | 0.81 | TSHR (0.45) | TDP1TSHRMAPK1HSD17B10ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3617281-B1 | SOLVENT COMPOSITION FOR ELECTRONIC DEVICE PRODUCTION | DAICEL CORP (JP) | 2024-04-17 | — | — | EP | claimed |
| US-11655381-B2 | Solvent composition for electronic device production | DAICEL CORPORATION (JP) | 2023-05-23 | — | — | US | claimed |
| US-11597851-B2 | Ink for screen printing | DAICEL CORPORATION (JP) | 2023-03-07 | — | — | US | claimed |
| US-20210115272-A1 | SOLVENT COMPOSITION FOR ELECTRONIC DEVICE PRODUCTION | DAICEL CORPORATION (JP) | 2021-04-22 | — | — | US | claimed |
| EP-3617281-A1 | SOLVENT COMPOSITION FOR PRODUCING ELECTRONIC DEVICE | Daicel Corporation (JP) | 2020-03-04 | — | — | EP | claimed |
| CN-102024562-A | Solvent composition for manufacturing laminated ceramic component | DAICEL CHEM CO LTD | 2011-04-20 | — | — | CN | claimed |
| US-12620777-B2 | Optical member, laser module including said optical member, and laser device | DAICEL CORPORATION (JP) | 2026-05-05 | — | — | US | disclosed |
| EP-4549055-A1 | INK COMPOSITION | Daicel Corporation (JP) | 2025-05-07 | — | — | EP | disclosed |
| EP-4523625-A1 | ELECTRODE DEVICE FOR LIVING BODY | Toppan Holdings Inc. (JP) | 2025-03-19 | — | — | EP | disclosed |
| US-20250057457-A1 | ELECTRODE DEVICE FOR LIVING BODY | TOPPAN HOLDINGS INC. (JP) | 2025-02-20 | — | — | US | disclosed |
| CN-112204468-B | Photosensitive transfer material, method for producing resin pattern, method for producing circuit wiring, and method for producing touch panel | 富士胶片株式会社 | 2024-09-17 | — | — | CN | disclosed |
| CN-112204467-B | Photosensitive transfer material, method for producing resin pattern, method for producing circuit wiring, and method for producing touch panel | 富士胶片株式会社 | 2024-04-30 | — | — | CN | disclosed |
| EP-3617281-B1 | SOLVENT COMPOSITION FOR ELECTRONIC DEVICE PRODUCTION | DAICEL CORP (JP) | 2024-04-17 | — | — | EP | disclosed |
| US-20080274305-A1 | Liquid Crystal Sealant and Liquid Crystal Display Cell Utilizing the Same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2008-11-06 | — | — | US | disclosed |
| EP-1780587-A1 | LIQUID CRYSTAL SEALANT AND LIQUID CRYSTAL DISPLAY CELL UTILIZING THE SAME | Nippon Kayaku Kabushiki Kaisha (JP) | 2007-05-02 | — | — | EP | disclosed |
| US-7101596-B2 | Liquid crystal sealant, liquid crystal display device using the same and method for producing the device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2006-09-05 | — | — | US | disclosed |
| EP-1674919-A1 | SEALANT FOR LIQUID CRYSTAL, LIQUID-CRYSTAL DISPLAY MADE WITH THE SAME, AND PROCESS FOR PRODUICNG THE DISPLAY | Nippon Kayaku Kabushiki Kaisha (JP) | 2006-06-28 | — | — | EP | disclosed |
| CN-1664707-A | Scouring agent and flushing fluid for the planography | DAICEL CHEM (JP) | 2005-09-07 | — | — | CN | disclosed |
| US-20050181145-A1 | Liquid crystal sealant, liquid crystal display device using the same and method for producing the device | SHARP KABUSHIKI KAISHA (JP) | 2005-08-18 | — | — | US | disclosed |
| US-6120858-A | COMPRISING AN EPOXY RESIN, A NOVOLAC RESIN, A CURING ACCELERATOR AND A TITANIUM BLACK PIGMENT | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2000-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210115272-A1 | SOLVENT COMPOSITION FOR ELECTRONIC DEVICE PRODUCTION | RER1, EFNA1, EPHA1 | TDP1 1268/4885TSHR 4809/4885MAPK1 19/4885 |
| US-12620777-B2 | Optical member, laser module including said optical member, and laser device | MARK3, OR10J3, ILK | TDP1 4063/4885TSHR 1155/4885MAPK1 1380/4885 |
| US-11655381-B2 | Solvent composition for electronic device production | RER1, EFNA1, EPHA1 | TDP1 1268/4885TSHR 4809/4885MAPK1 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.